Gene therapy for chronic pain management
Authors:
Open Access
- 3 October 2024
- journal article
- review article
- Published by Elsevier in Cell Reports Medicine
- Vol. 5 (10) , 101756
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of War (2210645)
- U.S. Department of War (W81XWH2110756)
- U.S. Department of War (W81XWH2110885)
- U.S. Department of War (W81XWH2210646)
- National Institute of Neurological Disorders and Stroke (R01NS13181201A1)
- Duke University
- School of Medicine, Duke University
- National Institutes of Health (R61NS138215)
This publication has 155 references indexed in Scilit:
- Emerging Role of PD-1 in the Central Nervous System and Brain DiseasesNeuroscience Bulletin, 2021
- Double VEGF/HGF Gene Therapy in Critical Limb Ischemia Complicated by Diabetes MellitusJournal of Cardiovascular Translational Research, 2020
- Regulation of Pain and Itch by TRP ChannelsNeuroscience Bulletin, 2017
- Results of an International Postmarketing Surveillance Study of pl-VEGF165 Safety and Efficacy in 210 Patients with Peripheral Arterial DiseaseAmerican Journal of Cardiovascular Drugs, 2017
- Lentiviral vector‐encoded microRNA‐based shRNA‐mediated gene knockdown ofN‐methyl‐D‐aspartate receptors in skin reduces painBrain and Behavior, 2016
- When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development ProgramArthritis & Rheumatology, 2015
- Physical Non-Viral Gene Delivery Methods for Tissue EngineeringAnnals of Biomedical Engineering, 2012
- A phase I clinical study of naked DNA expressing two isoforms of hepatocyte growth factor to treat patients with critical limb ischemiaThe Journal of Gene Medicine, 2011
- Bone Marrow Stromal Cells Produce Long-Term Pain Relief in Rat Models of Persistent PainStem Cells, 2011
- Gene therapy for pain: Results of a phase I clinical trialAnnals of Neurology, 2011